Oruka Therapeutics(DE:HQ1)
€90.00+1.50 (+1.69%)
DE:HQ1
Oruka Therapeutics stock drug pipeline
€90.00
At close:+1.50 (+1.69%)
Oruka Therapeutics (HQ1) Drug Pipeline
0 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oruka Therapeutics, Inc. (DE:HQ1) have in its pipeline
Oruka Therapeutics DE:HQ1 is currently developing the following drugs: Orka-002, Orka-001, Orka-001 Induction Dose, Orka-001 Maintenance Dose. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

